Cargando…

Role of CD68 in tumor immunity and prognosis prediction in pan-cancer

CD68 plays a critical role in promoting phagocytosis; however, the function of CD68 in tumor immunity and prognosis remains unknown. We analyzed CD68 expression among 33 tumor and normal tissues from The Cancer Genome Atlas and Genotype-Tissue Expression datasets. The relationship between CD68 expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jingwei, Li, Shuwang, Liu, Fangkun, Yang, Kui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098459/ https://www.ncbi.nlm.nih.gov/pubmed/35550532 http://dx.doi.org/10.1038/s41598-022-11503-2

Ejemplares similares

CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
por: Wang, Zeyu, et al.
Publicado: (2022)

Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022)

Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma
por: Liu, Fangkun, et al.
Publicado: (2019)

A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment
por: Wen, Jie, et al.
Publicado: (2021)

The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
por: Cheng, Lang, et al.
Publicado: (2023)

CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction
por: Li, Jian, et al.
Publicado: (2016)

Role of SERCA3 in the Prognosis and Immune Function in Pan-Cancer
por: Li, Jiajia, et al.
Publicado: (2022)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
por: Lu, Jun, et al.
Publicado: (2019)

Role of CD47 in tumor immunity: a potential target for combination therapy
por: Huang, Jing, et al.
Publicado: (2022)

Elevated CD163(+)/CD68(+) Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer
por: Yang, Chaogang, et al.
Publicado: (2019)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
por: Jia, Yan, et al.
Publicado: (2021)

Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
por: Li, Qiao, et al.
Publicado: (2023)

Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors
por: Zhang, Yajing, et al.
Publicado: (2022)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
por: Zhang, Ben, et al.
Publicado: (2023)

High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression
por: Su, Chong-Yu, et al.
Publicado: (2018)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
por: Li, Huanyu, et al.
Publicado: (2023)

A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment
por: Gong, Xun, et al.
Publicado: (2023)

CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis
por: Chen, Ying, et al.
Publicado: (2023)

Integration of OV6 expression and CD68(+) tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma
por: Wang, Ming-Da, et al.
Publicado: (2022)

Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma
por: Mavili, Hanife Seda, et al.
Publicado: (2021)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment
por: Shao, Wei, et al.
Publicado: (2023)

Immunologic Gene Sets Reveal Features of the Tumor Immune Microenvironment and Predict Prognosis and Immunotherapy Response: A Pan-Cancer Analysis
por: Pan, Hongda, et al.
Publicado: (2022)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer
por: He, Mingdong, et al.
Publicado: (2023)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

A Comprehensive and Systematic Analysis Revealed the Role of ADAR1 in Pan-Cancer Prognosis and Immune Implications
por: Zhu, Jianlin, et al.
Publicado: (2023)

Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
por: Huang, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojmq3icajm4ajg726tfuvm4u5v